TW434012B - Pharmaceutical composition for treating airway diseases in mammals - Google Patents

Pharmaceutical composition for treating airway diseases in mammals Download PDF

Info

Publication number
TW434012B
TW434012B TW085111379A TW85111379A TW434012B TW 434012 B TW434012 B TW 434012B TW 085111379 A TW085111379 A TW 085111379A TW 85111379 A TW85111379 A TW 85111379A TW 434012 B TW434012 B TW 434012B
Authority
TW
Taiwan
Prior art keywords
patent application
scope
item
composition according
pyruvate
Prior art date
Application number
TW085111379A
Other languages
English (en)
Chinese (zh)
Inventor
Stanley E Katz
Original Assignee
Cellular Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellular Sciences Inc filed Critical Cellular Sciences Inc
Application granted granted Critical
Publication of TW434012B publication Critical patent/TW434012B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW085111379A 1995-09-19 1996-09-18 Pharmaceutical composition for treating airway diseases in mammals TW434012B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US396295P 1995-09-19 1995-09-19

Publications (1)

Publication Number Publication Date
TW434012B true TW434012B (en) 2001-05-16

Family

ID=21708422

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085111379A TW434012B (en) 1995-09-19 1996-09-18 Pharmaceutical composition for treating airway diseases in mammals

Country Status (10)

Country Link
EP (1) EP0804181A4 (fr)
JP (1) JP4459303B2 (fr)
AU (1) AU719332B2 (fr)
CA (1) CA2205112C (fr)
IL (1) IL119225A (fr)
MX (1) MX9703653A (fr)
NZ (1) NZ306832A (fr)
TW (1) TW434012B (fr)
WO (1) WO1997010818A1 (fr)
ZA (1) ZA967833B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2373611C (fr) * 1999-05-14 2009-06-23 Cellular Sciences, Inc. Methode et composition permettant de traiter les maladies du nez et des sinus provoquees par une reaction inflammatoire chez les mammiferes
JP2004528307A (ja) * 2001-03-15 2004-09-16 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション サイトカインにより媒介される炎症性状態の治療のためのピルベートおよび／またはその誘導体の使用方法
US6623723B2 (en) * 2001-08-21 2003-09-23 Cellular Sciences Inc. Method for treating bronchial constriction and bronchospasm
US6689810B2 (en) * 2001-08-21 2004-02-10 Cellular Sciences, Inc. Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
US20030105162A1 (en) * 2001-08-21 2003-06-05 Celluar Sciences, Inc. Method for treating bronchial constriction and bronchospasm
US8076373B2 (en) * 2001-09-11 2011-12-13 North Cell Pharmacetical Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
JP5630750B2 (ja) * 2008-03-18 2014-11-26 国立大学法人 岡山大学 興奮性化学伝達調節剤およびそのスクリーニング法
US11571455B2 (en) 2013-04-11 2023-02-07 Vanderbilt University Methods and compositions for treating alcoholic liver disease
JP2020524144A (ja) 2017-06-16 2020-08-13 ヴァンダービルト ユニヴァーシティ 微生物性炎症を処置するための方法および組成物
EP3797766A1 (fr) * 2019-09-24 2021-03-31 Evonik Operations GmbH Compositions à utiliser pour réduire l'inflammation
KR20220097972A (ko) * 2019-11-14 2022-07-08 메르크 파텐트 게엠베하 세포 배양 배지

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1857M (fr) * 1962-03-08 1963-06-10 Roussel Uclaf Nouveau médicament notamment pour le traitement des maladies d'origine virale.
US3279997A (en) * 1963-10-22 1966-10-18 Herbert D Schneyer Enteric coated calcium lactate tablets containing an antihistamine and thiamine chloride
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
US3988470A (en) * 1974-02-25 1976-10-26 Scott Eugene J Van Treatment of palmar and plant disturbed keratosis
US4158057A (en) * 1975-03-28 1979-06-12 Stanko Ronald T Prevention of the accumulation of fatty deposits in the liver
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4197316A (en) * 1975-07-23 1980-04-08 Scott Eugene J Van Treatment of dry skin
US4234599A (en) * 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US4351835A (en) * 1981-04-01 1982-09-28 Montefiore Hospital Method for preventing body fat deposition in mammals
US4415576A (en) * 1981-04-01 1983-11-15 Montefiore Hospital Method for preventing body fat deposition in mammals
US4521375A (en) * 1982-11-23 1985-06-04 Coopervision, Inc. Sterilizing treatment with hydrogen peroxide and neutralization of residual amounts thereof
DE3302694A1 (de) * 1983-01-27 1984-08-02 Retheto Filmtechnik Theilemann & Co, 8000 München Mundpflegemittel
WO1986000227A1 (fr) * 1984-06-22 1986-01-16 Veech Richard L Solutions electrolytiques et leur utilisation in vivo
US4696917A (en) * 1985-08-01 1987-09-29 Lindstrom Richard L Irrigation solution
JPS63135370A (ja) * 1986-11-26 1988-06-07 Grelan Pharmaceut Co Ltd 抗アレルギ−剤
IN168530B (fr) * 1987-11-06 1991-04-20 Lyphomed Inc
WO1990000900A1 (fr) * 1988-07-20 1990-02-08 Amgen Inc. Procede de traitement de troubles inflammatoires par reduction de l'activation phagocytaire
JP2794021B2 (ja) * 1988-11-02 1998-09-03 エーザイ株式会社 アゼラスチン或いはその塩類含有経皮適用製剤
EP0477345A1 (fr) * 1990-03-30 1992-04-01 Amgen Inc. Facteurs d'inhibition des bouffees respiratoires
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5296370A (en) * 1990-10-04 1994-03-22 Rutgers, The State University Repair medium for the resuscitation of injured cells
US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
WO1993016690A1 (fr) * 1992-02-25 1993-09-02 Warner-Lambert Company Compositions cytoprotectrices contenant du pyruvate et des antioxydants
US5256697A (en) * 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
JP3236658B2 (ja) * 1992-04-27 2001-12-10 花王株式会社 気管支拡張剤
US5536751A (en) * 1994-05-09 1996-07-16 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof

Also Published As

Publication number Publication date
EP0804181A1 (fr) 1997-11-05
ZA967833B (en) 1997-06-02
AU6915996A (en) 1997-04-09
WO1997010818A1 (fr) 1997-03-27
AU719332B2 (en) 2000-05-04
IL119225A0 (en) 1996-12-05
NZ306832A (en) 2001-04-27
EP0804181A4 (fr) 2005-02-02
JPH10509463A (ja) 1998-09-14
IL119225A (en) 2000-09-28
CA2205112C (fr) 2008-11-18
MX9703653A (es) 1998-07-31
CA2205112A1 (fr) 1997-03-27
JP4459303B2 (ja) 2010-04-28

Similar Documents

Publication Publication Date Title
CA2597395C (fr) Methode et composition de traitement chez les mammiferes de maladies et de lesions provoquees par la surexpression du peroxynitrite
US20020006961A1 (en) Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
CN1175903A (zh) 治疗腺苷衰竭的方法
DE60126814T2 (de) Inhalation von stickoxid
AU1328501A (en) Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase
PL203216B1 (pl) Zastosowanie lecznicze hydroksyetylorutozydów, kompozycja farmaceutyczna zawierająca hydroksyetylorutozydy oraz sól Zn²⁺ i/lub kompleks Zn²⁺, zestaw zawierający hydroksyetylorutozydy oraz sól Zn²⁺ i/lub kompleks Zn²⁺, oraz zastosowanie lecznicze kompozycji farmaceutycznej lub zestawu zawierającego hydroksyetylorutozydy oraz sól Zn²⁺ i/lub kompleks Zn²⁺
TW434012B (en) Pharmaceutical composition for treating airway diseases in mammals
US5952384A (en) Method and composition for treating mammalian diseases caused by inflammatory response
US10813893B2 (en) Compositions and methods for the treatment and prevention of chronic hypoxemia and dyspnea
JP5895303B2 (ja) Ｎ−アセチル−ｌ−システインを含む新規な組み合わせおよびその使用
DE69821498T2 (de) Verwendung von amifostin
WO2015014209A1 (fr) Compositions pharmaceutiques de pyruvate pour la stabilité osmotique et effet de désintoxication de celles-ci chez des êtres humains en bonne santé et des patients atteints d'affections pulmonaires
WO2021034298A1 (fr) Compositions et méthodes permettant le traitement et la prévention de l'hypoxie et de la dyspnée
JP2011190274A (ja) 炎症反応により生ずる哺乳動物の鼻および副鼻洞の病気を処置する方法および組成物
RU2242972C2 (ru) Ингаляционный состав для лечения бронхиальной астмы
DE60022070T2 (de) Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MK4A Expiration of patent term of an invention patent